Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Inection Point Acquisition Corp. VII - Class A Ordinary Shares
Sage Group ADR
Victorias Secret & Co. Common Stock
Edit Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
ProPhase Labs, Inc. - Common Stock
(NQ:
PRPH
)
0.3626
UNCHANGED
Last Price
Updated: 4:00 PM EST, Jan 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ProPhase Labs, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
ProPhase Labs's Earnings: A Preview
↗
March 14, 2024
Via
Benzinga
ProPhase Labs Earnings Preview
↗
November 08, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
August 29, 2023
On Tuesday, 99 stocks hit new 52-week lows.
Via
Benzinga
DSS, Inc.'s (NYSE American: DSS) Subsidiary Appoints New Chief Investment Officer To Aggressively Develop Mutual Fund Business For Eventual Spinoff
↗
July 26, 2023
DSS Wealth, Inc. has appointed Daniel Lew as its new Chief Investment Officer (CIO) and Portfolio Manager. DSS Wealth is a mutual fund and a wholly-owned subsidiary of DSS, Inc.
Via
Benzinga
Analyst Expectations for ProPhase Labs's Future
↗
May 12, 2023
Via
Benzinga
Recap: ProPhase Labs Q1 Earnings
↗
May 11, 2023
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
↗
April 10, 2023
Via
Benzinga
ProPhase Labs Earnings Preview
↗
March 27, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
August 11, 2023
During the Friday's sesion, 157 stocks hit new 52-week lows.
Via
Benzinga
DSS Inc. Is Spinning Off Its Biotech Subsidiary After Signing A Major Licensing Agreement
June 27, 2023
DSS Inc. Is Spinning Off Its Biotech Subsidiary After Signing A Major Licensing Agreement
Via
News Direct
DSS Inc. Is Spinning Off Its Biotech Subsidiary After Signing A Major Licensing Agreement
June 27, 2023
By David Willey, Benzinga
Via
TheNewswire.com
A Look Into Healthcare Sector Value Stocks
↗
January 23, 2023
Via
Benzinga
5 Value Stocks In The Healthcare Sector
↗
January 09, 2023
Via
Benzinga
ProPhase Labs's Return On Capital Employed Overview
↗
December 20, 2022
Via
Benzinga
5 Value Stocks In The Healthcare Sector
↗
December 05, 2022
Via
Benzinga
Earnings Scheduled For August 10, 2023
↗
August 10, 2023
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.
Via
Benzinga
DSS Inc. Is Spinning Off Its Biotech Subsidiary After Signing A Major Licensing Agreement
↗
June 26, 2023
DSS, Inc.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
June 01, 2023
Via
Benzinga
7 Small-Cap Biotech Stocks with Massive Potential
↗
April 27, 2023
Although small-cap biotech stocks present high risks, if they hit one out of the park, the rewards can be astronomical.
Via
InvestorPlace
Impact Biomedical Preparing A Potential Spinoff — What Does This Mean For Investors Of Holding Company DSS, Inc (NYSE American: DSS)?
↗
March 27, 2023
Impact Biomedical, a biotechnology company focused on developing innovative treatments for a wide range of diseases and conditions and one of the key businesses in the DSS Inc. (NYSE American: DSS)...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
January 11, 2023
Via
Benzinga
ProPhase Labs to Present at the Planet MicroCap Showcase: VIRTUAL 2022 on Wednesday, December 7, 2022
November 30, 2022
From
ProPhase Labs, Inc.
Via
GlobeNewswire
ProPhase Labs Announces Record Third Quarter 2022 Financial Results
November 10, 2022
From
ProPhase Labs, Inc.
Via
GlobeNewswire
ProPhase Labs Announces Collaboration with Dana-Farber Cancer Institute
November 08, 2022
From
ProPhase Labs, Inc.
Via
GlobeNewswire
ProPhase Labs to Present at Investor Summit Group’s Q4 Conference
November 07, 2022
From
ProPhase Labs, Inc.
Via
GlobeNewswire
ProPhase Labs to Host Third Quarter 2022 Financial Results Conference Call on Thursday, November 10, 2022 at 11:00 a.m. Eastern Time
November 04, 2022
From
ProPhase Labs, Inc.
Via
GlobeNewswire
ProPhase Labs Announces Collaboration with G42 Healthcare
October 19, 2022
From
ProPhase Labs, Inc.
Via
GlobeNewswire
Why Olaplex Shares Dipped Around 57%; Here Are 75 Biggest Movers From Yesterday
↗
October 20, 2022
Gainers Amprius Technologies, Inc. (NYSE: AMPX) jumped 77.3% to settle at $11.01 on Wednesday after the company announced it was awarded a $50 million cost-sharing grant from the U.S. Department of...
Via
Benzinga
Why United Airlines Shares Are Trading Higher? Here Are 43 Stocks Moving In Wednesday's Mid-Day Session
↗
October 19, 2022
Gainers SenesTech, Inc. (NASDAQ: SNES) shares jumped 102.6% to $0.47 after declining over 3% on Tuesday. SenesTech, during August, posted a Q2 loss of $0.21 per share.
Via
Benzinga
ProPhase Labs to Present at The ThinkEquity Conference
October 18, 2022
From
ProPhase Labs, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
